tirzepatide sublingual drops reviews Oral reviews: what users report and what the science says Sublingual GLP-1/GIP (Tirz) Oral Drops

Sourcing quality GHK-Cu Quality matters significantly with copper peptides

Pancreatitis has been reported with GLP-1 receptor agonists

PMID: 26243373

Plant Physiol 155(1):218

Serious side effects (rare but important): Gallbladder problems (risk increases with rapid weight loss) Pancreatitis (inflammation of pancreas) Thyroid C-cell tumors (seen in animal studies, not confirmed in humans) Severe gastroparesis (stomach paralysis in extreme cases) Hypoglycemia if combined with other diabetes drugs Who shouldn't use these drugs: Personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 History of pancreatitis Severe gastroparesis or digestive issues Pregnant or trying to conceive Dosing and injection frequency Both drugs are once-weekly injections

However, the lack of a placebo control group limits interpretation, as placebo responses in eating disorder trials can be substantial